Volver a Agenda
Session Chair(s)
David Ohlssen, PHD
Senior Expert Methodologist
Novartis Pharmaceuticals Corporation, United States
Learning Objective : Discuss the importance of Bayesian methods in drug development; Examine comparative effectiveness and medical product development case studies; Identify the strategies for education in Bayesian methods.
Speaker(s)
An Overview of the Bayesian DIA Working Group
Karen Lynn Price, PHD
Eli Lilly and Company, United States
Senior Research Fellow, Statistical Innovation Center/Design Hub
Hierarchical Bayesian Methods for Combining Efficacy and Safety in Multiple Treatment Comparisons
Bradley P. Carlin, PHD, MS
PharmaLex, United States
Senior Advisor, Data Science and Statistics
Panelist
Lisa LaVange, PHD
University of North Carolina at Chapel Hill, United States
Professor Emerita
¿Tiene una cuenta?